Curo Oncology

Pretoria, Gauteng 0084

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Progressive Brain Metastasis, Unresectable or Metastatic Melanoma

Studies at this site

• A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma — Running, not enrolling
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling